Day: February 26, 2024

Results for the Quarter and Fiscal Year Ended December 31, 2023 and Other Recent Highlights:Net investment income per share for the quarter was $0.46, compared to $0.43 for the quarter ended September 30, 2023 Net asset value per share as of the end of the quarter was $15.41, compared to $15.28 as of September 30, 2023, an increase of 0.9% due to net investment income in excess of the dividend and a net gain on the portfolio New investment commitments made during the quarter totaled $175 million(1) Gross fundings, excluding revolver fundings(2), totaled $114 million for the quarter Net repayments, including revolvers(2), totaled $47 million for the quarter Net leverage(3) was 1.34x as of December 31, 2023 Declared a dividend of $0.38 per share for the quarter ending December 31, 2023(4) Completed Collateralized Loan Obligation (“CLO”)...

4Q’23 Marketplace Revenue further accelerated to 10% YoY, fastest pace in 10 quarters 4Q’23 Consolidated Net Loss of $(22.6) million, down 197% YoY; 4Q’23 Non-GAAP Consolidated Adjusted EBITDA of $61.2 million, up 120% YoY Repurchased $99.9 million worth of shares in 4Q’23 and a total of $204.1 million worth of shares in FY 2023 CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) — CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today announced financial results for the fourth quarter and year ended December 31, 2023. “We are extremely pleased with our performance, as our Marketplace business continued to accelerate in the fourth quarter, achieving the fastest pace of growth in nearly three years,” said Jason Trevisan, Chief Executive...

CIRM Grant Awarded to Support Phase 1 Autoimmunity Study of FT819 CD19-targeted CAR T-cell Program for Systemic Lupus Erythematosus; Study Start-up Ongoing at Multiple Clinical Sites First Patient Treated in Phase 1 Study of FT522 ADR-armed, CD19-targeted CAR NK Cell Program; Dose Escalation Designed to Assess 3-dose Treatment Schedule with and without Chemotherapy Conditioning Phase 1 Study Initiated of FT825 / ONO-8250 CAR T-cell Program for Solid Tumors; Incorporates Seven Synthetic Controls including Novel Cancer-specific CAR Targeting HER2 $316 Million in Cash, Cash Equivalents, and Investments SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular...

TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — Canadian Life Companies Split Corp. (“the Company”) announces that its annual financial statements and management report of fund performance for the year ended November 20, 2023 are now available on the Company’s website at www.lifesplit.com and will also be available on www.sedarplus.com. For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.lifesplit.com.  

TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — TDb Split Corp. (“the Company”) announces that its annual financial statements and management report of fund performance for the year ended November 30, 2023 are now available on the Company’s website at www.tdbsplit.com and will also be available at www.sedarplus.com. For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.tdbsplit.com. Investor Relations: 1-877-478-2372Local: 416-304-4443www.tdbsplit.cominfo@quadravest.com

TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — New Commerce Split (“the Company”) announces that its annual financial statements and management report of fund performance for the year ended November 30, 2023 are now available on the Company’s website at www.commercesplit.com and will also be available at www.sedarplus.com. For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.commercesplit.com. Investor Relations: 1-877-478-2372  Local: 416-304-4443  www.commercesplit.com  info@quadravest.com 

TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — M Split Corp. (“the Company”) announces that its annual financial statements and management report of fund performance for the year ended November 30, 2023 are now available on the Company’s website at www.m-split.com and will also be available at www.sedarplus.com. For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.m-split.com.

TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — US Financial 15 Split Corp (“the Company”) announces that its annual financial statements and management report of fund performance for the year ended November 30, 2023 are now available on the Company’s website at www.financial15.com and will also be available at www.sedarplus.com.  For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.financial15.com.

TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — Financial 15 Split Corp. (“the Company”) announces that its annual financial statements and management report of fund performance for the year ended November 30, 2023 are now available on the Company’s website at www.financial15.com and will also be available on www.sedarplus.com. For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.financial15.com.